Dihydroergotamine Mesylate 4 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Nasal Spray
Available Strengths: 4 mg/mL
Originator reference: Migranal (USA/EU) (brand names belong to their owners and are shown only to identify the originator medicine)
Category: Neurology
Dihydroergotamine is an ergot alkaloid used to treat acute migraine attacks and cluster headaches. It works by constricting blood vessels in the brain and reducing inflammation around cranial nerves, which helps relieve migraine symptoms.
Manufacture or export Dihydroergotamine Mesylate? List it or send an offer →
Product Description:
Dihydroergotamine is a hydrogenated ergot alkaloid with broad receptor activity: agonism at 5-HT1B/1D/1F, plus adrenergic and dopaminergic effects. Compared with ergotamine it is a weaker arterial constrictor and a stronger venoconstrictor, which gives it a better cardiovascular margin. Its clinical value in migraine is a long duration of action and a low headache recurrence rate, and it can work late in an attack when triptans have failed.
The nasal spray avoids injection and the poor, erratic oral bioavailability that made oral forms unreliable; it is primed and given as one spray in each nostril, repeated after fifteen minutes. Nausea is less of a problem than with ergotamine. The critical safety issue is a boxed warning: combined with strong CYP3A4 inhibitors — macrolide antibiotics, azole antifungals, HIV protease inhibitors — it can cause serious peripheral and cerebral ischaemia. It must not be given within twenty-four hours of a triptan.
Sourcing notes. The spray is a device-drug combination, so the metering pump, spray pattern and droplet size are part of the specification and of any bioequivalence case, not just the solution. The solution is light-sensitive and packed in amber vials. Registration of intranasal DHE is limited; many markets register only the injection. Ergot derivatives also attract precursor-chemical scrutiny in some jurisdictions.
Dihydroergotamine Mesylate — third party manufacturing & bulk supply
Dihydroergotamine Mesylate 4 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Dihydroergotamine Mesylate is supplied as Nasal Spray — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Dihydroergotamine Mesylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Dihydroergotamine Mesylate →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Related Products
Droxidopa
Strength:
100 mg, 200 mg, 300 mg
Form: Capsules
Originator reference: Northera (USA)
View DetailsGivinostat
Strength:
8.86 mg/mL
Form: Oral suspension
Originator reference: Duvyzat (USA/EU)
View DetailsabobotulinumtoxinA
Strength:
300U, 500U
Form: Injection
Originator reference: Dysport (USA), Azzalure (EU)
View DetailsDextroamphetamine Sulfate
Strength:
2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg
Form: Tablets, Capsules
Originator reference: Dexedrine (USA), Zenzedi (USA)
View DetailsValproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Originator reference: Depakene (USA), Depakine (EU/LATAM)
View DetailsTolebrutinib Tablets
Strength:
60 mg
Form: Film-coated tablets
Originator reference: Cenrifki
View DetailsUsually answered within 48 hours | GMP documents shared before you commit